Skip to main content
Premium Trial:

Request an Annual Quote

Accelr8 Quadruples Q3 Revenues, But Loss Widens as it Prepares Bacterial Analysis System

NEW YORK, June 16 (GenomeWeb News) - Accelr8 Technology yesterday reported increased revenues along with a widened loss for its third quarter of fiscal 2005, which ended April 30.


The Denver-based company had $120,000 in revenues for the quarter, more than four times the $26,000 it posted during the same period a year ago. This increase was attributed to sales of two types of microarray slides, Slide H and Slide HS, which Accelr8 licenses and manufactures for Schott Nexterion.


Research and development costs nearly tripled for the quarter, however, to $383,000, from $128,000 during the same quarter last year. the company attributed the increase to the development of its BACcelr8r rapid bacterial analysis system.


As a result, Accelr8's net loss for the quarter soared to $563,000, or $.06 per share, from $335,000, or $.03 per share, during the year-ago period.


As of April 30, Accelr8 had $5.9 million in cash and cash equivalents.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.